1Jing N, Marchand C, Liu J, et al. Mechanism of inhibition of HIV-1 integrase by G-tetrad-forming oligonucleotides in vitro [J]. J Biol Chem, 2000, 275(28):21460-21467.
2Gottfredsson M, Bohjanen PR. Human immunodeficiency virus type Ⅰ as a target for gene therapy[J]. Front Biosci,1997, 2:619- 634.
3d'Angelo J, Mouscadet JF, Desmaele D, et al. HIV-1 integrase: the next target for AIDS therapy[J]? Pathol Biol (Paris), 2001, 49(3) :237 - 246.
4Patrick H, Jonathan L. Retroviral DNA integration [J].Microbiol Mol Biol Rev,1999,63(4):836-843.
5Joseph PG. Retroviral integrase: conserved sequence information as a guide to understanding structure and function of the retroviral and bacterial IS3 DD(35) E transposases [J]. J Mol Struct (Theochem), 1998, 423(1/2) :41 -57.
6Bujacz G, Jaskolski M, Alexandratos J, et al. High-resolution structure of the catalytic domain of avian sarcoma virus integrase[J]. J Mol Biol, 1995, 253(2):333-346.
7Pommier Y, Marchand C, Neamati N. Retroviral integrase inhibitors year 2000: update and perspectives[J]. Antiviral Res, 2000, 47(3): 139 - 148.
8Neamati N, Sunder S, Pommier Y. Design and discovery of HIV-1 integrase inhibitors[J]. Ther Focus, 1997, 2(11):486 - 498.
9Mazumder A, Uchida H, Neamati N, et al. Probing interactions between viral DNA and human immunodeficiency virus type 1 integrase using dinucleotides[J]. Mol Pharmacol, 1997, 51(4) :567- 575.
10Taktakishvili M, Neamati N, Pommier Y, et al. Recognition and inhibition of HIV integrase by a novel dinucleotide[J]. Bioorg Med Chem Lett, 2000, 10(3):249-251.
